Alyglo Interactions
There are 104 drugs known to interact with Alyglo (immune globulin intravenous), along with 3 disease interactions. Of the total drug interactions, 85 are major, 18 are moderate, and 1 is minor.
- View Alyglo disease interactions (3)
Medications known to interact with Alyglo
Note: Showing generic names only.
- adefovir
- amikacin
- amikacin liposome
- amphotericin b
- amphotericin b cholesteryl sulfate
- amphotericin b lipid complex
- amphotericin b liposomal
- capreomycin
- celecoxib
- chikungunya vaccine, live (cvx 317)
- cholera vaccine, live
- cidofovir
- cisplatin
- colistimethate
- cyclosporine
- ibandronate
- ibuprofen
- indomethacin
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, live
- inotersen
- iobenguane I 131
- measles virus vaccine
- meclofenamate
- mefenamic acid
- meloxicam
- mephenytoin
- mesalamine
- methotrexate
- methoxyflurane
- monomethyl fumarate
- moxetumomab pasudotox
- mumps virus vaccine
- pamidronate
- pentamidine
- phenylbutazone
- phenytoin
- piroxicam
- plazomicin
- poliovirus vaccine, live, trivalent
- polymyxin b
- pozelimab
- tacrolimus
- telavancin
- temsirolimus
- tenofovir alafenamide
- tenofovir disoproxil
- tobramycin
- tolmetin
- typhoid vaccine, live
Alyglo disease interactions
There are 3 disease interactions with Alyglo (immune globulin intravenous) which include:
More about Alyglo (immune globulin intravenous)
- Alyglo consumer information
- Compare alternatives
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: immune globulins
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.